Tag: cancer
Unprecedented successes regarding cancer immunotherapy have been achieved, in which therapeutic agents are used to targeting immune cells rather than cancer cells.
6 days ago
 
A growing number of studies have investigated the malignancy risk associated with systemic lupus erythematosus (SLE), and our review will focus mainly (though not exclusively) on studies published in the past year.
8 days ago
 
Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of systemic autoimmune diseases (collectively referred to as myositis), which mainly include the subtypes of polymyositis, dermatomyositis, immune-mediated necrotizing myopathy (IMNM) and sporadic inclusion body myositis (sIBM).
9 days ago
 
Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of systemic autoimmune diseases (collectively referred to as myositis), which mainly include the subtypes of polymyositis, dermatomyositis, immune-mediated necrotizing myopathy (IMNM) and sporadic inclusion body myositis (sIBM).
23.08.2019
 
Cancer and autoimmune diseases are the two devastating conditions that together constitute a leading health problem worldwide. The rising burden of these disorders in the developing world demands a multifaceted approach to address the challenges it poses.
11.07.2019
 
Immunotherapy is an umbrella term used to describe therapies that directly target the immune system to combat disease. For many years, immunotherapy has mainly been used to diminish immune responses in diseases traditionally classified as immunemediated, such as autoimmunity and allergy, and to promote tolerance to transplanted tissues and organs.
28.06.2019
 
By targeting inhibitory checkpoint molecules, with resultant reinvigoration of antitumor immunity, immune checkpoint inhibitors (ICIs) have opened a new chapter in cancer treatment [1].
27.03.2019
 
Specific differences in cancer risk have been observed between systemic lupus erythematosus patients and the general population. Although meta-analyses have estimated cancer incidence in systemic lupus erythematosus patients, results have been inconclusive.
25.03.2019
 
Our understanding of the pivotal role the immune system plays in the pathogenesis of many diseases is continually expanding. Huge advances have been made in elucidating the complex immunologic background of several diseases, including Alzheimer’s disease, Parkinson’s disease, and asthma [1,2].
15.03.2019
 
Autoantibody specificity and disease subtype are biologically meaningful filters that may inform cancer risk stratification in patients with scleroderma. Future research testing the value of targeted cancer screening strategies in patients with scleroderma is needed. Recent studies that demonstrate autoantibodies are powerful tools to interrogate molecular events linking cancer and the development of autoimmunity in scleroderma.
23.07.2018